FAK contributes to tumor progression by enhancing cell motility, invasion, and resistance to apoptosis. It facilitates the detachment of cancer cells from the primary tumor, aids in their migration through the ECM, and supports their survival in the circulatory system. Moreover, FAK interacts with other oncogenic signaling molecules, amplifying the malignant phenotype of cancer cells.
